80427-2-RR

antibody from Proteintech Group

Targeting: SMAD2 JV18-1, MADH2, MADR2

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Chromatin Immunoprecipitation (Data presented on provider website)

Antibody Data

Product number

80427-2-RR

Provider

Proteintech Group

Product name

Phospho-SMAD2 (Ser465/467)/SMAD3 (Ser423/425) monoclonal antibody

Antibody type

Recombinant

Description

Phospho-SMAD2 (Ser465/467)/SMAD3 (Ser423/425) monoclonal antibody (Catalog no. 80427-2-RR) is a rabbit recombinant antibody that shows reactivity with human and has been validated for the following applications: WB, IF/ICC, FC (Intra), ELISA, ChIP-qPCR

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

240826D11

References

Submitted references

Bisdemethoxycurcumin attenuates myocardial fibrosis in heart failure with preserved ejection fraction by targeting TGFBR1 and oxidative stress.

Xu R, Cao G, Hou L, Fu W, Bi C, Li X, Wang X
Computational and structural biotechnology journal 2026;31:422-435

---

Huanggan decoction ameliorates cholestatic hepatic fibrosis in rats via TGF-β1/Smad3 signaling pathway.

Lei Y, Ma X, Jin X, He Y, Yang J, Zhao Y, Chen J, Gao T
PloS one 2026;21(3):e0344168

---

Mechanism of Platelet-Rich Plasma in Promoting Diabetic Wound Healing via the PI3K/AKT Signaling Pathway to Regulate Collagen Synthesis and Angiogenesis.

Liu H, Huang W, Jiang S, Yan B, Kong C, Zhu W, Xie Q, Cui C
Journal of diabetes research 2026;2026(1):e1254597

---

YTHDF2 promotes arsenic carcinogenesis through m(6)A-dependent SMAD7 decay and PRR5 escape from decay.

Zhang Q, Man J, Cai J, Zhao T, Zhang Z
International journal of biological macromolecules 2026 Mar;348:150816

---

A Brain-Targeting Curcumin Analog Inhibits Glioblastoma Progression Through THBS1/TGF-β1/PI3K-AKT Axis Modulation: Evidence From Experimental and Bioinformatic Analyses.

Han Z, Li X, Zhu Y, Wang Z, Hou Y, Tao H, Ma M, Xie X, Zhang H
Journal of cellular and molecular medicine 2026 Mar;30(5):e71065

---

CD14+ Monocytes Will Become a New Target for the Treatment of Osteoporosis: Based on Mendel Randomization, Clinical Analysis and Cell Experiment Verification.

Wang H, Ma X, Zhou P, Zhang J, Wang B, Liu J
Journal of cellular and molecular medicine 2026 Jan;30(2):e71024

---

SULT1E1 suppresses hepatocellular carcinoma progression via activation of the TGF-β/SMAD signaling pathway and cell cycle arrest.

Zhang W, Peng J, Dai D, Huang C, Liu F, Chen X
BMC gastroenterology 2026 Feb 11;26(1)

---

Mechanism of IFITM1 regulating epidural scar hyperplasia after laminectomy through SMAD3/CBR4 pathway.

Wang H, Zhu Z, Liu J
Frontiers in immunology 2025;16:1628970

---

Discovery of protein lactylation-associated biomarkers and their potential pathogenic mechanisms in recurrent spontaneous abortion.

Yan X, Wang X, Sun X, Jiao J
International journal of biological macromolecules 2025 Sep;321(Pt 4):146004

---

CRABP2 promotes peritoneal metastasis in CRC through TGF-β/Smad-mediated EMT signaling and invadopodia formation.

Hao W, Dong X, Wang Z, Wen T, Liu L, Gu T, Ma H
Cellular signalling 2025 Oct;134:111927

---

TSN Disrupts Fanconi Anemia Pathway Activation Through JAK/STAT1-Mediated Transcriptional Repression of FA Core Subunits in Bladder Cancer.

Zhao W, Xie Z, Zhu L, Li W
Dose-response : a publication of International Hormesis Society 2025 Oct-Dec;23(4):15593258251406039

---

METTL3/IGF2BP2 stabilizes IQGAP3 via m6A modification to drive HCC metastasis through TGF-β/Smad signaling and EMT.

Pan D, Zhang H, Zhou J, He S, Yuan G
Pathology, research and practice 2025 Nov;275:156228

---

Multi-omics analyses, cell experiments, and network pharmacology tools identified key proteins and candidate drugs for alopecia areata treatment.

Bi L, Wang J, Yang J, Zhuang Z, Chen K, Xu Z, Zuo X, Xu J, Sheng Y, Cui Y
Clinical proteomics 2025 May 29;22(1):22

---

Reduced glutathione enhances adipose tissue-derived mesenchymal stem cell engraftment efficiency for liver fibrosis by targeting TGFβ1/SMAD3/NOX4 pathway.

Yu S, Wang Y, Shi Y, Yu S, Zhao B, Liao N, Liu X
Bioengineering & translational medicine 2025 Mar;10(2):e10735

---

Omentin-1 attenuates atrial fibrillation via Src/PI3K/Akt signaling-mediated anti-fibrotic effects in cardiac fibroblasts.

Li TL, Zhu NN, Zhao MX, Sun J, Yin Z, Xie P, Huang JH, Guo JP, Yuan HT, Li SX, Zhao-Liang S
European journal of pharmacology 2025 Jun 5;996:177588

---

[PSMD11 overexpression promotes epithelial-mesenchymal transition in gastric cancer and affects patient prognosis].

Zhou R, Yang J, Song B, Chen X, Wang L, Wang Y, Zuo L, Zhu B
Nan fang yi ke da xue xue bao = Journal of Southern Medical University 2025 Dec 20;45(12):2747-2755

---

Integrated Proteomics Reveals Spliceosome Dysregulation and Highlights DHX9 as a TGF-β Signaling-Driven Fibrosis Hub in Endometriosis.

Yang M, Zhang L, Ding X, Wei P, Zhang H, Chen J, Zhang Y, Li D, Chen Z, Lin D, Huang Z, Chen Q
Journal of proteome research 2025 Aug 1;24(8):4044-4059

---

Sodium Hyaluronate-PDGF Repairs Cartilage and Subchondral Bone Microenvironment via HIF-1α-VEGF-Notch and SDF-1-CXCR4 Inhibition in Osteoarthritis.

Wang Z, Zhu P, Li H, Ye B, Luo Q, Cheng J, Cai Y
Journal of cellular and molecular medicine 2025 Apr;29(7):e70515

---

ErTao decoction alleviates liver fibrosis by suppressing STING-mediated macrophages and NLRP3 inflammasome activation.

Jia H, Li J, Chen X, Liu Z, Wu C, Liu C, Zhang J, Luo M, Huang M, Huang S, Cai M, Gao L
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Apr;139:156489

---

Autophagy inhibition enhances antifibrotic potential of placental mesenchymal stem cells of fetal origin via regulating TGF-β1 mediated protein degradation of HGF.

Zhou W, Wang J, Ding L, Cai R, Cheng J, Liang P, Zhu Y, Zhang Z
Scientific reports 2025 Apr 21;15(1):13805

---

FATP5 modulates biological activity and lipid metabolism in prostate cancer through the TEAD4-mediated Hippo signaling.

Liu S, He Y, Gu Z
Frontiers in oncology 2024;14:1442911